NEA Management Company’s Acrivon Therapeutics ACRV Stock Holding History

NEA Management Company’s Portfolio ACRV Stock Details ACRV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$1.29M	Hold
2023 Q3	$4.11M	Sell
2023 Q2	$6.24M	Hold
2023 Q1	$4.89M	Hold
2022 Q4	$4.44M	Buy